Santen Pharmaceutical Co., Ltd.

¥1,894As of Sun 8 Nov 2026, 12:00 UTC
TSE:4536Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 4.19%
Div yield 2.22%
ROE 13.58%
Drug Manufacturers (General)
Beta (5Y) 0.22
PE TTM 15.70
TSR TTM 28.44%
Mkt cap ¥608.3B
ROIC 17.01%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,872
(1.14%)
5.09%
Hold 3|4|1|6|3
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
17.33
16.91
18.76
18.27
(1.66%)
(2.55%)
10.42%
5.62%
Revenue¥B
64.59
64.30
67.05
65.30
9.24%
11.27%
12.19%
5.96%
Peers (US$3.862B)
Cap (US$)
PE
28.14B
11.52x
3.643B
17.14x
Capital
TTM
5Y
10Y
Leveragex
1.192
0.127
0.110
EBIT/Intx
2.871
0.494
0.531
Own earn%
62.99
(3.81)
(2.87)
Sh yield%
37.93
26.06
27.13
Owners
Insiders/Inst%
12.46
62.18
Short interest%
5.99
SBC / revenue%
1.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
25–31
$1 testx
—
Incr. ROIC%
−13